About: http://data.cimple.eu/news-article/ecc34a774ea8b477eb9236eb8c78fab1e6fe8610e18d34cc79678a8a

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/ecc34a774ea8b477eb9236eb8c78fab1e6fe8610e18d34cc79678a8a Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Uzbekistan on Wednesday became the latest country to certify Russia's Sputnik V coronavirus vaccine for mass use, saying it planned to purchase one million doses for the country of 34 million. Two-shot Sputnik V is leading the vaccine race in Central Asia, a five-country former Soviet region with close political and economic ties to Moscow. Uzbekistan's state coronavirus commission said Sputnik V was "certified and approved for mass use in Uzbekistan" and the country was "taking practical measures" to secure an initial batch of one million doses. The news comes after a pharmaceutical factory in neighbouring Kazakhstan said on Tuesday that it had gained approval from Kazakh authorities to produce and distribute Sputnik V. The factory expects to distribute 90,000 doses by the end of February. In Uzbekistan, Sputnik V is likely to face competition from a vaccine developed by the Chinese pharmaceutical company Anhui Zhifei Longcom Biopharmaceutical. The state coronavirus commission said Wednesday that the country was planning to begin production of the Chinese vaccine later this year, after launching phase three trials in the capital Tashkent in December. Kazakhstan, Central Asia's second most populous country with around 19 million people, is the first country other than Russia to host production of Sputnik V. A spokesman for the Russian Direct Investment Fund (RDIF) that financed Sputnik V's development said Monday that Brazil, India and South Korea are expected to follow. Isolated Turkmenistan, which claims to have no cases of the coronavirus, was the first Central Asian country to register the Sputnik V vaccine, but has provided no information about its vaccination campaign. Kyrgyzstan, one of the region's poorest countries, is in negotiations with Russia to secure up to half a million doses of Sputnik V for free, health minister Alymkadyr Beishanaliyev said on Monday. Russia registered Sputnik V -- named after the Soviet-era satellite -- in August, months ahead of Western competitors but before the start of large-scale clinical trials, which left some experts wary. But top medical journal The Lancet published a new analysis of the vaccine this month declaring it 91.6 percent effective. sk-cr/mm/jv
schema:headline	Uzbekistan certifies Russia's Sputnik vaccine for mass use
schema:mentions	Uzbekistan Medical journal Populous (company) Kazakhstan Pharmaceutical industry Sputnik 1 Soviet Union Satellite The Lancet Asia Moscow South Korea Russia India Brazil Vaccine China Severe acute respiratory syndrome coronavirus 2 Anhui The Factory Russian Direct Investment Fund Tashkent Central Asia Turkmenistan Biopharmaceutical Kyrgyzstan
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-02-17 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	82 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software